stella
beta
Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer — Stella
Home
/
Hormone Receptor Positive HER-2 Negative Breast Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to Hormone Receptor Positive HER-2 Negative Breast Cancer trials
Trial locations
(1 site)
Germany
Department of Women's Health, Tübingen